Your browser doesn't support javascript.
loading
Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood.
van der Pan, Kyra; de Bruin-Versteeg, Sandra; Damasceno, Daniela; Hernández-Delgado, Alejandro; van der Sluijs-Gelling, Alita J; van den Bossche, Wouter B L; de Laat, Inge F; Díez, Paula; Naber, Brigitta A E; Diks, Annieck M; Berkowska, Magdalena A; de Mooij, Bas; Groenland, Rick J; de Bie, Fenna J; Khatri, Indu; Kassem, Sara; de Jager, Anniek L; Louis, Alesha; Almeida, Julia; van Gaans-van den Brink, Jacqueline A M; Barkoff, Alex-Mikael; He, Qiushui; Ferwerda, Gerben; Versteegen, Pauline; Berbers, Guy A M; Orfao, Alberto; van Dongen, Jacques J M; Teodosio, Cristina.
Afiliação
  • van der Pan K; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • de Bruin-Versteeg S; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Damasceno D; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Hernández-Delgado A; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • van der Sluijs-Gelling AJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • van den Bossche WBL; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • de Laat IF; Department of Immunology, Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Díez P; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Naber BAE; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Diks AM; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Berkowska MA; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • de Mooij B; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Groenland RJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • de Bie FJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Khatri I; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Kassem S; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • de Jager AL; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Louis A; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Almeida J; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • van Gaans-van den Brink JAM; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Barkoff AM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
  • He Q; Institute of Biomedicine, Research Center for Infections and Immunity, University of Turku (UTU), Turku, Finland.
  • Ferwerda G; Institute of Biomedicine, Research Center for Infections and Immunity, University of Turku (UTU), Turku, Finland.
  • Versteegen P; Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands.
  • Berbers GAM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
  • Orfao A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
  • van Dongen JJM; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Teodosio C; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
Front Immunol ; 13: 935879, 2022.
Article em En | MEDLINE | ID: mdl-36189252
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Células Mieloides / Anticorpos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Células Mieloides / Anticorpos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article